159 related articles for article (PubMed ID: 11996475)
1. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers.
Fujimoto J; Aoki I; Khatun S; Toyoki H; Tamaya T
Ann Oncol; 2002 Mar; 13(3):430-4. PubMed ID: 11996475
[TBL] [Abstract][Full Text] [Related]
2. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.
Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889
[TBL] [Abstract][Full Text] [Related]
3. Clinical implications of expression of ETS-1 related to angiogenesis in uterine endometrial cancers.
Fujimoto J; Aoki I; Toyoki H; Khatun S; Tamaya T
Ann Oncol; 2002 Oct; 13(10):1605-11. PubMed ID: 12377649
[TBL] [Abstract][Full Text] [Related]
4. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers.
Sato E; Fujimoto J; Tamaya T
Oncology; 2007; 73(3-4):246-51. PubMed ID: 18424889
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers.
Fujimoto J; Sakaguchi H; Aoki I; Tamaya T
Cancer Res; 2000 May; 60(10):2632-5. PubMed ID: 10825134
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers.
Toyoki H; Fujimoto J; Sato E; Sakaguchi H; Tamaya T
Ann Oncol; 2005 Jan; 16(1):51-5. PubMed ID: 15598938
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of expression of ETS-1 related to angiogenesis in uterine cervical cancers.
Fujimoto J; Aoki I; Toyoki H; Khatun S; Tamaya T
Ann Oncol; 2002 Oct; 13(10):1598-604. PubMed ID: 12377648
[TBL] [Abstract][Full Text] [Related]
8. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma.
Wagatsuma S; Konno R; Sato S; Yajima A
Cancer; 1998 Feb; 82(3):520-30. PubMed ID: 9452270
[TBL] [Abstract][Full Text] [Related]
10. [Angiogenesis-prognostic factor in patients with endometrial cancer].
Mazurek A; Kuć P
Ginekol Pol; 2005 Oct; 76(10):838-45. PubMed ID: 16417101
[TBL] [Abstract][Full Text] [Related]
11. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers.
Fujimoto J; Hori M; Ichigo S; Tamaya T
Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
Soeda S; Nakamura N; Ozeki T; Nishiyama H; Hojo H; Yamada H; Abe M; Sato A
Gynecol Oncol; 2008 Apr; 109(1):122-8. PubMed ID: 18289648
[TBL] [Abstract][Full Text] [Related]
13. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
14. Macrophage infiltration and angiogenesis in endometrial cancer.
Hashimoto I; Kodama J; Seki N; Hongo A; Miyagi Y; Yoshinouchi M; Kudo T
Anticancer Res; 2000; 20(6C):4853-6. PubMed ID: 11205231
[TBL] [Abstract][Full Text] [Related]
15. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers.
Fujimoto J; Ichigo S; Sakaguchi H; Hirose R; Tamaya T
Cancer Lett; 1998 Aug; 130(1-2):115-20. PubMed ID: 9751263
[TBL] [Abstract][Full Text] [Related]
16. Prospective clinical study of the association between plasma level of free IGF-1 and myometrial invasion min patients with endometrial adenocarcinoma.
Baloglu A; Bezircioglu I; Cetinkaya B; Hicyilmaz L
Ginekol Pol; 2010 Jul; 81(7):501-5. PubMed ID: 20825050
[TBL] [Abstract][Full Text] [Related]
17. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid-dependent angiogenesis in uterine endometrial cancers.
Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma.
Li W; Xu RJ; Zhang HH; Jiang LH
Int J Gynecol Cancer; 2006; 16(4):1673-8. PubMed ID: 16884383
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in endometrial carcinoma: correlation with survival and clinicopathologic risk factors.
Ozuysal S; Bilgin T; Ozan H; Kara HF; Oztürk H; Ercan I
Gynecol Obstet Invest; 2003; 55(3):173-7. PubMed ID: 12865598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
